These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 24899728

  • 21. Potential role of iron in repair of inflammatory demyelinating lesions.
    Lee NJ, Ha SK, Sati P, Absinta M, Nair G, Luciano NJ, Leibovitch EC, Yen CC, Rouault TA, Silva AC, Jacobson S, Reich DS.
    J Clin Invest; 2019 Oct 01; 129(10):4365-4376. PubMed ID: 31498148
    [Abstract] [Full Text] [Related]

  • 22. Different pathological processes for acute white matter lesions in multiple sclerosis.
    Alturkustani M, Bahakeem B, Zhang Q, Ang LC.
    Malays J Pathol; 2020 Aug 01; 42(2):187-194. PubMed ID: 32860370
    [Abstract] [Full Text] [Related]

  • 23. Ex vivo MR microscopy of a human brain with multiple sclerosis: Visualizing individual cells in tissue using intrinsic iron.
    Nair G, Dodd S, Ha SK, Koretsky AP, Reich DS.
    Neuroimage; 2020 Dec 01; 223():117285. PubMed ID: 32828923
    [Abstract] [Full Text] [Related]

  • 24. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
    Mallik S, Muhlert N, Samson RS, Sethi V, Wheeler-Kingshott CA, Miller DH, Chard DT.
    Mult Scler; 2015 Apr 01; 21(4):423-32. PubMed ID: 25145689
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Exploring the origins of grey matter damage in multiple sclerosis.
    Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R.
    Nat Rev Neurosci; 2015 Mar 01; 16(3):147-58. PubMed ID: 25697158
    [Abstract] [Full Text] [Related]

  • 28. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, Magliozzi R, Allen I, McDonnell G, Kee R, Naughton M, Fitzgerald DC, Reynolds R, Neal JW, Howell OW.
    Ann Neurol; 2018 Dec 01; 84(6):829-842. PubMed ID: 30362156
    [Abstract] [Full Text] [Related]

  • 29. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.
    Gorter RP, Nutma E, Jahrei MC, de Jonge JC, Quinlan RA, van der Valk P, van Noort JM, Baron W, Amor S.
    Clin Exp Immunol; 2018 Nov 01; 194(2):137-152. PubMed ID: 30014472
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.
    Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N.
    J Neurol Neurosurg Psychiatry; 2009 Feb 01; 80(2):182-7. PubMed ID: 18829630
    [Abstract] [Full Text] [Related]

  • 32. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
    Lassmann H.
    Front Immunol; 2018 Feb 01; 9():3116. PubMed ID: 30687321
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I, Saji E, Nishizawa M.
    Rinsho Shinkeigaku; 2014 Feb 01; 54(12):1060-2. PubMed ID: 25672709
    [Abstract] [Full Text] [Related]

  • 35. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H.
    J Neurol Sci; 2013 Oct 15; 333(1-2):1-4. PubMed ID: 23735777
    [Abstract] [Full Text] [Related]

  • 36. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Peterson JW, Bö L, Mörk S, Chang A, Trapp BD.
    Ann Neurol; 2001 Sep 15; 50(3):389-400. PubMed ID: 11558796
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
    Brück W.
    J Neurol; 2005 Nov 15; 252 Suppl 5():v10-5. PubMed ID: 16254696
    [Abstract] [Full Text] [Related]

  • 39. Altered human oligodendrocyte heterogeneity in multiple sclerosis.
    Jäkel S, Agirre E, Mendanha Falcão A, van Bruggen D, Lee KW, Knuesel I, Malhotra D, Ffrench-Constant C, Williams A, Castelo-Branco G.
    Nature; 2019 Feb 15; 566(7745):543-547. PubMed ID: 30747918
    [Abstract] [Full Text] [Related]

  • 40. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
    Yarnykh VL, Krutenkova EP, Aitmagambetova G, Repovic P, Mayadev A, Qian P, Jung Henson LK, Gangadharan B, Bowen JD.
    AJNR Am J Neuroradiol; 2018 Apr 15; 39(4):618-625. PubMed ID: 29439122
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.